Bilateral deep vein thrombosis (DVT) should prompt investigation for pro-thrombotic conditions and the exclusion of vascular compromise due to intrinsic and extrinsic factors. The authors present the case of a 47-year-old man admitted with bilateral DVT and diagnosed with inferior vena cava (IVC) infra-renal segment agenesis, and discuss the management of this rare condition.
Deep venous thrombosis, absence of inferior vena cava, inferior vena cava anomalies
Congenital malformation and agenesis of the inferior vena cava (IVC) are extremely rare vascular anomalies, being present in only 0.0005–1% of the general population[1]. The absence of the infra-renal segment of IVC seems to be the rarest anomaly[2,3], with KILT syndrome (kidney anomaly, IVC anomaly and leg thrombosis) also beingvery uncommon[1]. Frequently, these are incidental findings on imaging studies but have been reported during abdominal surgery or when difficulties arise during femoral catheterization.
A 47-year-old man was admitted to our hospital with complaints of nausea, lumbar and lower limb pain and oedema, which had started the month before but had worsened during the previous week, to the point of rendering him unable to walk.
The patient reported no trauma, recent surgery, acute illness, recent immobilization, long-range flights or known triggers of his symptoms. His history included prostatitis at age 34 and elective cholecystectomy at age 37. He reported no medication, alcohol, tobacco or recreational drug use. However, he did mention that his sister and her son have had DVT, that his nephew had been diagnosed with a factor V Leiden mutation, and that his family had never been formally studied.
On physical examination, he appeared well, was alert, calm, normothermic and haemodynamically stable, and showed no signs of respiratory distress. He presented pain and bilateral erythematous pitting oedema up to the inguinal ligament, but no other relevant changes.
Figure 1. Contrast-enhanced coronal reformatted CT scan showing iliac vein thrombosis (red arrow) and absence of the inferior vena cava (yellow arrow)
Figure 2. Contrast-enhanced axial CT scan showing collateral venous drainage through the azygos system
Figure 3.Ultrasound view of the external jugular vein thrombosis
In light of the age and family history of the patient, a search for a prothrombotic condition that could have triggered the thrombosis was conducted, and included screening for subclinical infectious diseases (blood cultures and serologies for HIV, hepatitis B, C and syphilis were all negative), autoimmune diseases (negative for lupus and phospholipid syndrome antibodies) and indolent malignancies (upper endoscopy and colonoscopy, thyroid and testicular echography, free and total prostatic specific antigen dosing, beta-2-microglobulin, immunoglobulins and protein electrophoresis, the results of which were all normal).
Symptomatic control was achieved with anticoagulation, analgesics, and early but gradual ambulation, and the patient was discharged after 7 days.
After the acute phase had resolved, follow-up tests for protein S, C, ATIII and homocysteine levels were all normal. At 5-month follow-up, the lower limb complaints had been controlled with postural and compressive measures,while repeated imaging studies showed partial recanalization of the iliac veins.
Multidisciplinary team follow-up with the collaboration of immunohaemotherapy and vascular surgery specialists will be conducted in order to monitor the patient for symptomatic complications of post-thrombotic syndrome.
Highlighting of rare cases is essential so that future patients can be managed correctly. Patients with IVC anomalies can remain asymptomatic as long as there is functioning collateral venous drainage. However, when prothrombotic or venous insufficiency risk factors are present, symptoms may start to develop, usually with signs of venous insufficiency, pelvic congestion syndrome, DVT and compression syndromes from dilated collateral vascularization[4].
Conservative therapy with anticoagulation, compression stockings and management of complications seem to be the mainstay of treatment, but invasive surgical interventions with an endovascular approach or even prosthetic replacement of the IVC have also been reported, with successful results[1,5].